Pathocare Pathology Laboratories Private Limited
Founded: 2022
Status: Under Process Of Striking Off
Designation: Director
VP
Viralkumar Ashvinbhai Patel - Profile
Viralkumar Ashvinbhai Patel, Director and Designated Partner, with 4 companies.
About
Viralkumar Ashvinbhai Patel
Viralkumar Ashvinbhai Patel has 7 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Pathocare Pathology Laboratories Private Limited and Epione Medical Services Private Limited. Formerly with 1 company, such as Civilix Industries Private Limited. Engaged in General Business. Contributes to corporate operations.
Current Companies
3
Past Companies
1
Total Affiliations
4
Oldest Company Age
7
Companies Associated with Viralkumar Ashvinbhai Patel
Current Companies
Epione Medical Services Private Limited
Founded: 2018
Status: Strike Off
Designation: Director
Summit Multiventures Llp
Founded: 2025
Status: Active
Designation: Designated Partner
Previous Companies
Civilix Industries Private Limited
Founded: 2021
Status: Active
Designation: Director
Explore Director's current and past company associations— Uncover their professional journey today!
Frequently Asked Questions
Who is Viralkumar Ashvinbhai Patel?
Viralkumar Ashvinbhai Patel has 7 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Pathocare Pathology Laboratories Private Limited and Epione Medical Services Private Limited. Formerly with 1 company, such as Civilix Industries Private Limited. Engaged in General Business. Contributes to corporate operations.
What is Viralkumar Ashvinbhai Patel's role in current companies?
Viralkumar Ashvinbhai Patel is associated with 3 companies as Director and Designated Partner.
What industries does Viralkumar Ashvinbhai Patel specialize in?
Viralkumar Ashvinbhai Patel has expertise in General Business.
How many years of experience does Viralkumar Ashvinbhai Patel have?
Viralkumar Ashvinbhai Patel has 7 years in corporate governance.